2-Pyrrolidinecarboxamide,N-[(3R,4S,7S)-3-ethyl-3-methyl-7-(2-methylpropyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-1-methyl-,(2S)- (23926-97-8)

Identification
Name:	2-Pyrrolidinecarboxamide,N-[(3R,4S,7S)-3-ethyl-3-methyl-7-(2-methylpropyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-1-methyl-,(2S)-
Synonyms:	2-Pyrrolidinecarboxamide,N-[3-ethyl-3-methyl-7-(2-methylpropyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-1-methyl-,[3R-[3R,4S(S),7S]]-; Ceanothine D (8CI);2-Oxa-6,9-diazabicyclo[10.2.2]hexadecane, 2-pyrrolidinecarboxamide deriv.
CAS:	23926-97-8
Molecular Formula:	C26H38 N4 O4
Molecular Structure:
Properties
Safety Data

Other Product

Pentanamide,2-(dimethylamino)-4-methyl-N- [(3R,4S,7S)-3-(1-methylethyl)-7-(2-methylpropyl)- 5,8-dioxo-2-oxa-6,9-diazabicyclo- [10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-,(2S)-
Pentanamide,2-(dimethylamino)-N-[(3R,4S,7S)-7-[(R)-hydroxyphenylmethyl]-5,8-dioxo-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-3-methyl-,(2S,3R)-
N-[(3S,4S,7S,10Z)-7-benzyl-3-(1-methylethyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),10,12,15-tetraen-4-yl]-1-methyl-L-prolinamide
Pentanamide,3-methyl-2-(methylamino)-N- [(3R,4S,7S)-3-(1-methylethyl)-7-(2-methylpropyl)- 5,8-dioxo-2-oxa-6,9-diazabicyclo- [10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-,(2S,3S)-
Benzenepropanamide, a-(dimethylamino)-N-[(3R,4S,7S)-3-(1-methylethyl)-7-(2-methylpropyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-,(aR)-
Benzenepropanamide,R-(dimethylamino)-N- [(3R,4S,7S)-3-(1-methylethyl)-7-[(1R)-1- methylpropyl]-5,8-dioxo-2-oxa-6,9- diazabicyclo[10.2.2]hexadeca-10,12,14,15- tetraen-4-yl]-,(RS)-
(2S,3R)-2-Dimethylamino-3-methyl-N-[(3R,4S,7S)-7-(2-methylpropyl)-5,8-dioxo-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-12,14(1),15-trien-4-yl]pentanamide
(2S,3R)-2-Dimethylamino-3-methyl-N-[(3R,4S,7S)-7-(2-methylpropyl)-5,8-dioxo-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14(1),15-tetren-4-yl]pentanamide
(2S,3R)-N-[(3R,4S,7S)-7-Benzoyl-5,8-dioxo-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14(1),15-tetren-4-yl]-2-(dimethylamino)-3-methylpentanamide
L-Prolinamide,N-methyl-L-phenylalanyl-N-[(3R,4S,7S)-5,8-dioxo-3-phenyl-7-(phenylmethyl)-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-(9CI)
Benzenepropanamide, a-(dimethylamino)-N-[(3R,4S,7S)-7-(2-methylpropyl)-5,8-dioxo-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-,(aS)-
(2S)-2-Dimethylamino-N-[(3R,4S,7S)-5,8-dioxo-3-phenyl-7-phenylmethyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-12,14(1),15-trien-4-yl]-3-methylbutanamide
(2S)-2-Dimethylamino-N-[(3R,4S,7S)-5,8-dioxo-3-phenyl-7-phenylmethyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14(1),15-tetren-4-yl]-3-methylbutanamide
L-Prolinamide,N-methyl-L-phenylalanyl-N-[(3R,4S,7S)-3-(1-methylethyl)-7-(2-methylpropyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-(9CI)
Nalpha,Nalpha-dimethyl-N-[(3R,4S,7S,10Z)-7-[(1S)-1-methylpropyl]-5,8-dioxo-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),10,12,15-tetraen-4-yl]-L-phenylalaninamide
N~2~,N~2~-dimethyl-N-[(3S,4S,7S,10Z)-3-(1-methylethyl)-7-(2-methylpropyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),10,12,15-tetraen-4-yl]-L-alloisoleucinamide
N~2~,N~2~-dimethyl-N-[(3S,4S,7S,10Z)-3-(1-methylethyl)-7-[(1S)-1-methylpropyl]-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),10,12,15-tetraen-4-yl]-L-leucinamide
N-[(3R,4S,7S,10Z)-7-benzyl-5,8-dioxo-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),10,12,15-tetraen-4-yl]-N~2~,N~2~-dimethyl-L-leucinamide
L-Prolinamide,N,N-dimethyl-L-phenylalanyl-N-[(3R,4S,7S)-5,8-dioxo-3-phenyl-7-(phenylmethyl)-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-(9CI)
(S)-α-Dimethylamino-N-[(3R,4S,7S)-3-isopropyl-5,8-dioxo-7-benzyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14(1),15-tetren-4-yl]benzenepropanamide